Bumrungrad in Thailand serves more than 1.1 million patients per year and will benefit from BC Platforms’ end-to-end integrated software solution to bring genetic data from the lab to the clinic. This will allow Bumrungrad to support advanced personalized care and research. Bumrungrad will also provide its data and samples to BC Platforms’ global biobank network, BCRQUEST.COM, which will increase the diversity of this resource providing genomic and clinical cohort data for pharmaceutical and medical research and development. BC Platforms is a Debiopharm Innovation Fund portfolio company.
